Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 146 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
JAZZ	JAZZ PHARMACEUTICALS PLC	$14.43B	0.70%	0.30%	-0.39%	-0.50%	1.62	2.04	88.00%	0.70%	-0.85%
ICCC	IMMUCELL CORP	$88.57M	-1.90%	-1.20%	-1.30%	-1.10%	0.51	4.82	42.60%	-1.80%	-1.75%
EXEL	EXELIXIS INC	$13.77B	40.20%	30.50%	45.14%	46.40%	0.34	3.26	96.40%	35.10%	42.23%
PLX	PROTALIX BIOTHERAPEUTICS INC	$185.31M	28.10%	17.80%	27.76%	44.50%	0.52	3.15	70.00%	20.10%	27.24%
AUPH	AURINIA PHARMACEUTICALS INC	$2.22B	64.50%	47.60%	21.65%	25.00%	0.28	5.55	89.70%	100.00%	46.27%
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.33B	735.00%	3.20%	14.87%	13.00%	29.13	2.12	85.90%	3.80%	12.92%
RPRX	ROYALTY PHARMA PLC	$32.38B	8.50%	4.30%	6.03%	4.50%	0.99	2.66	100.00%	33.90%	47.67%
FENC	FENNEC PHARMACEUTICALS INC	$382.80M	-54.80%	-14.20%	-10.89%	-23.20%	0.91	6.98	92.20%	-16.40%	-13.28%
FBIO	FORTRESS BIOTECH INC	$91.68M	152.90%	54.00%	56.33%	216.20%	0.95	2.86	66.20%	180.20%	215.81%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$4.55B	13.30%	9.90%	15.85%	25.20%	0.36	3.79	89.30%	9.70%	14.06%
ONC	BEONE MEDICINES LTD	$31.15B	12.10%	6.70%	11.16%	23.00%	0.80	3.64	88.30%	8.90%	13.11%
ALNY	ALNYLAM PHARMACEUTICALS INC	$38.90B	98.30%	11.80%	23.01%	17.20%	3.77	3.13	80.80%	13.50%	20.29%
LQDA	LIQUIDIA CORP	$6.95B	46.80%	7.10%	20.74%	26.40%	2.70	2.22	91.80%	7.70%	18.13%
VCYT	VERACYTE INC	$4.83B	6.90%	6.30%	6.57%	42.50%	0.07	9.31	70.90%	16.20%	16.75%
ABUS	ARBUTUS BIOPHARMA CORP	$904.72M	129.30%	112.20%	59.11%	137.60%	0.07	54.26	100.00%	84.00%	84.00%
HALO	HALOZYME THERAPEUTICS INC	$8.89B	126.30%	14.70%	22.62%	21.60%	11.17	2.76	82.80%	23.10%	34.64%
INCY	INCYTE CORP	$22.73B	29.20%	21.70%	30.37%	79.50%	0.31	3.68	92.50%	26.70%	33.13%
PTGX	PROTAGONIST THERAPEUTICS INC	$7.84B	-17.80%	-16.50%	-17.40%	-22.40%	0.06	17.76	100.00%	-154.90%	-155.78%
PBYI	PUMA BIOTECHNOLOGY INC	$412.79M	20.40%	12.10%	25.77%	47.90%	0.50	2.38	74.50%	10.70%	15.08%
REGN	REGENERON PHARMACEUTICALS INC	$66.35B	14.30%	11.10%	14.55%	15.20%	0.30	3.57	84.50%	29.60%	34.89%
VTVT	VTV THERAPEUTICS INC	$138.18M	4.00%	2.90%	2.46%	-35.70%	0.10	14.36	100.00%	6.10%	6.13%
AGEN	AGENUS INC	$126.18M	-23.00%	30.90%	-193.93%	658.20%	-1.87	0.38	99.30%	52.00%	98.29%
PRTA	PROTHENA CORP PUBLIC LTD CO	$524.58M	-49.90%	-42.30%	-33.63%	622.40%	0.12	10.43	100.00%	-260.90%	-184.21%
IMCR	IMMUNOCORE HOLDINGS PLC	$1.57B	-7.10%	-2.50%	0.03%	0.00%	1.72	4.18	98.90%	-6.70%	0.07%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$1.61B	-44.70%	-14.80%	-12.40%	-14.70%	1.63	5.91	29.30%	-51.10%	-40.60%
STTK	SHATTUCK LABS INC	$493.82M	-60.70%	-55.70%	-50.96%	-188.80%	0.07	22.07	100.00%	-4,987.40%	-4,987.40%
FTRE	FORTREA HOLDINGS INC	$1.67B	-79.10%	-16.30%	-20.47%	-28.40%	4.10	0.95	18.90%	-16.50%	-13.26%
TARS	TARSUS PHARMACEUTICALS INC	$2.71B	-14.20%	-8.90%	-8.00%	-9.70%	0.67	3.74	93.50%	-9.00%	-6.54%
INVA	INNOVIVA INC	$1.74B	47.60%	32.40%	34.30%	58.30%	0.37	21.13	73.70%	119.90%	146.77%
CUE	CUE BIOPHARMA INC	$102.72M	-98.30%	-53.70%	-80.25%	-306.00%	0.43	3.57	100.00%	-59.60%	-57.58%
PGEN	PRECIGEN INC	$2.09B	-3,317.10%	-270.30%	-168.17%	-128.90%	5.85	4.82	80.10%	-1,213.50%	-625.55%
SRPT	SAREPTA THERAPEUTICS INC	$1.78B	4.90%	1.90%	0.91%	0.80%	1.11	4.63	62.90%	3.00%	1.12%
KRYS	KRYSTAL BIOTECH INC	$10.97B	19.30%	17.60%	16.08%	27.50%	0.09	9.46	94.20%	53.90%	49.68%
SEPN	SEPTERNA INC	$1.68B	-9.40%	-6.60%	-7.26%	-10.80%	0.51	4.71	100.00%	-49.90%	-49.40%
PRLD	PRELUDE THERAPEUTICS INC	$348.85M	-118.20%	-66.10%	-99.84%	-117.90%	0.99	2.03	100.00%	-465.30%	-465.30%
BMRN	BIOMARIN PHARMACEUTICAL INC	$11.40B	4.40%	3.40%	5.24%	7.10%	0.38	5.81	76.50%	8.30%	12.60%
ZVRA	ZEVRA THERAPEUTICS INC	$799.24M	81.30%	45.60%	60.94%	67.80%	0.35	4.89	86.10%	101.60%	115.40%
OABI	OMNIAB INC	$365.33M	-20.30%	-18.10%	-19.73%	-78.00%	0.12	4.80	98.90%	-187.60%	-190.93%
VCEL	VERICEL CORP	$2.36B	6.40%	4.60%	5.24%	5.50%	0.36	5.18	74.80%	7.30%	7.86%
NVO	NOVO NORDISK A S	$214.63B	66.40%	23.30%	46.60%	55.60%	1.75	0.79	81.80%	37.20%	47.49%
INSM	INSMED INC	$22.41B	-130.10%	-51.60%	-63.90%	-62.60%	1.95	4.47	81.80%	-144.40%	-133.71%
CAI	CARIS LIFE SCIENCES INC	$5.23B	-78.30%	-38.90%	8.91%	17.10%	0.96	7.05	68.70%	-45.30%	10.00%
ORMP	ORAMED PHARMACEUTICALS INC	$191.12M	55.30%	49.90%	45.10%	64.80%	0.13	6.45	N/A	N/A	N/A
ASND	ASCENDIS PHARMA A	$16.20B	-5,435.60%	35.80%	7.06%	7.60%	3.11	1.00	89.00%	57.30%	7.15%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$3.38B	-1.40%	-0.60%	4.07%	3.70%	1.43	2.68	90.90%	-0.60%	2.91%
ROIV	ROIVANT SCIENCES LTD	$24.51B	-6.90%	-5.70%	-3.07%	-4.30%	0.09	18.37	84.40%	-3,629.20%	-2,015.04%
PTCT	PTC THERAPEUTICS INC	$7.00B	N/A	-6.80%	-3.52%	-6.70%	-16.90	2.44	92.50%	-22.60%	-8.28%
NUVB	NUVATION BIO INC	$1.97B	-44.10%	-23.80%	-23.68%	-21.70%	0.91	7.44	90.80%	-102.10%	-87.84%
LXRX	LEXICON PHARMACEUTICALS INC	$1.13B	-18.60%	-11.80%	-6.95%	-12.50%	0.33	18.80	99.50%	-37.50%	-25.84%
HCWB	HCW BIOLOGICS INC	$6.94M	-1,138.00%	-68.20%	-17.38%	-16.20%	3.75	0.09	100.00%	-277.00%	-19.61%
VRTX	VERTEX PHARMACEUTICALS INC	$124.70B	23.90%	17.20%	22.90%	31.70%	0.37	3.02	86.20%	35.50%	42.36%
OMER	OMEROS CORP	$627.49M	-54.40%	34.50%	39.48%	16.70%	-5.52	3.03	94.10%	871.00%	904.87%
ANAB	ANAPTYSBIO INC	$1.84B	N/A	-7.80%	-9.25%	-5.80%	24.86	7.58	100.00%	-11.50%	-11.46%
TVTX	TRAVERE THERAPEUTICS INC	$5.47B	-26.80%	-3.80%	-2.42%	-1.90%	4.62	3.13	98.60%	-4.00%	-1.94%
ENTA	ENANTA PHARMACEUTICALS INC	$407.10M	-64.00%	-20.20%	-19.19%	-18.40%	1.70	3.84	100.00%	-89.60%	-74.39%
RLYB	RALLYBIO CORP	$84.77M	-14.40%	-13.30%	-15.53%	-30.10%	0.08	12.92	100.00%	-911.10%	-911.07%
KZIA	KAZIA THERAPEUTICS LTD	$805.99M	-217.80%	-51.20%	-52.23%	207.80%	0.53	2.87	100.00%	-1,200.90%	-1,285.72%
SLN	SILENCE THERAPEUTICS PLC	$478.48M	N/A	-53.70%	-71.69%	-94.10%	-1.33	9.83	79.50%	-8,943.90%	-8,942.55%
NAGE	NIAGEN BIOSCIENCE INC	$272.38M	25.40%	18.20%	21.52%	118.30%	0.39	4.61	64.30%	14.30%	15.10%
ARGX	ARGENX SE	$54.90B	20.20%	17.40%	17.42%	34.00%	0.19	5.23	N/A	N/A	N/A
URGN	UROGEN PHARMA LTD	$1.68B	N/A	-62.80%	-60.50%	-59.20%	-3.04	4.69	89.90%	-94.80%	-87.44%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$3.35B	-24.30%	-9.90%	-9.05%	-8.60%	1.30	3.35	75.30%	-16.80%	-12.84%
PTN	PALATIN TECHNOLOGIES INC	$20.35M	-141.40%	-58.10%	-58.39%	260.00%	0.25	5.04	100.00%	-48.50%	-48.45%
ADAG	ADAGENE INC	$198.55M	-41.00%	-21.00%	-32.86%	113.30%	0.75	3.07	100.00%	-229.60%	-227.41%
SPRO	SPERO THERAPEUTICS INC	$130.86M	35.60%	25.00%	28.95%	165.70%	0.12	10.50	100.00%	24.90%	25.33%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$2.05B	17.20%	12.00%	20.07%	48.50%	0.40	3.58	76.50%	16.20%	23.54%
JANX	JANUX THERAPEUTICS INC	$911.11M	-11.80%	-11.20%	-11.81%	-11.90%	0.09	17.01	100.00%	-833.60%	-833.60%
INDP	INDAPTUS THERAPEUTICS INC	$386.16M	-1,028.80%	-299.70%	-1,511.20%	929.90%	0.75	2.34	N/A	N/A	N/A
SLS	SELLAS LIFE SCIENCES GROUP INC	$2.30B	-47.10%	-42.60%	-27.35%	4,971.60%	0.06	17.22	N/A	N/A	N/A
UTHR	UNITED THERAPEUTICS CORP	$23.03B	19.20%	17.20%	26.58%	30.40%	0.14	4.79	86.60%	40.60%	51.27%
TECH	BIO-TECHNE CORP	$11.12B	5.50%	4.30%	6.49%	12.30%	0.22	4.49	65.00%	9.00%	12.86%
MGNX	MACROGENICS INC	$305.74M	-147.80%	-28.40%	-47.34%	-26.80%	9.28	1.90	74.40%	-44.80%	-36.75%
CBIO	CRESCENT BIOPHARMA INC	$511.74M	-100.90%	-88.20%	-85.98%	1,853.70%	0.08	13.78	100.00%	-1,494.60%	-1,466.29%
XLO	XILIO THERAPEUTICS INC	$54.14M	-117.20%	-21.40%	-25.97%	108.70%	1.25	3.59	100.00%	-58.50%	-58.52%
GERN	GERON CORP	$846.81M	-28.00%	-12.10%	-7.75%	-5.50%	1.33	6.78	97.30%	-34.30%	-18.21%
KYMR	KYMERA THERAPEUTICS INC	$8.89B	-25.00%	-22.30%	-19.59%	-26.80%	0.08	10.81	100.00%	-612.00%	-611.26%
ADMA	ADMA BIOLOGICS INC	$2.03B	39.00%	27.40%	36.10%	39.40%	0.70	6.95	61.30%	32.40%	41.89%
TAOX	TAO SYNERGIES INC	$26.75M	-134.10%	-109.50%	-83.05%	-152.70%	0.21	27.40	100.00%	-3,783.50%	-3,615.43%
RANI	RANI THERAPEUTICS HOLDINGS INC	$91.18M	-245.50%	-85.60%	-72.07%	-144.10%	0.58	3.40	100.00%	-929.10%	-864.78%
IFRX	INFLARX NV	$138.80M	-94.90%	-70.70%	-114.27%	-126.30%	0.33	4.16	-24,646.30%	-146,303.90%	-146,091.95%
ALEC	ALECTOR INC	$206.51M	-295.20%	-40.90%	-62.94%	-60.60%	22.11	5.25	100.00%	-680.80%	-679.92%
AVTX	AVALO THERAPEUTICS INC	$956.69M	-97.50%	-72.40%	-95.79%	-123.50%	0.46	7.66	100.00%	-143,627.10%	-143,340.68%
ARDX	ARDELYX INC	$1.37B	-38.10%	-11.90%	-9.22%	-6.60%	2.40	3.49	92.50%	-13.60%	-8.52%
TGTX	TG THERAPEUTICS INC	$8.55B	87.40%	42.80%	11.17%	13.50%	1.62	5.81	83.10%	66.00%	21.41%
NAMS	NEWAMSTERDAM PHARMA CO NV	$3.89B	-29.80%	-27.40%	-31.98%	-106.30%	0.10	9.76	100.00%	-942.80%	-942.76%
PYPD	POLYPID LTD	$86.47M	-366.30%	-143.80%	-229.81%	-391.20%	1.03	1.97	N/A	N/A	N/A
KPTI	KARYOPHARM THERAPEUTICS INC	$231.39M	N/A	-176.90%	-1,045.36%	-88.40%	-1.50	1.08	96.00%	-129.00%	-97.64%
MRNA	MODERNA INC	$26.69B	-36.70%	-26.60%	-34.51%	-33.60%	0.55	2.41	22.10%	-143.60%	-141.03%
QTTB	Q32 BIO INC	$223.32M	230.70%	53.30%	62.72%	217.40%	0.38	5.36	100.00%	61.90%	61.86%
ANL	ADLAI NORTYE LTD	$399.60M	-414.00%	-67.20%	472.51%	547.00%	-5.14	0.65	100.00%	-710.60%	-679.94%
ASMB	ASSEMBLY BIOSCIENCES INC	$424.97M	-4.20%	-3.10%	-3.18%	-5.10%	0.19	6.65	N/A	N/A	N/A
TBPH	THERAVANCE BIOPHARMA INC	$908.88M	43.80%	25.50%	31.49%	62.00%	0.63	13.14	100.00%	104.30%	126.38%
NRXS	NEURAXIS INC	$90.03M	-205.90%	-115.30%	-121.14%	604.80%	0.52	2.89	85.00%	-188.60%	-167.82%
BCRX	BIOCRYST PHARMACEUTICALS INC	$2.53B	N/A	-97.30%	-140.55%	-44.00%	-1.84	1.91	97.80%	-51.70%	-42.79%
CRMD	CORMEDIX INC	$615.85M	50.40%	27.40%	27.34%	86.10%	0.87	2.98	85.80%	45.20%	46.94%
IONS	IONIS PHARMACEUTICALS INC	$12.65B	-58.60%	-10.10%	-8.60%	-6.10%	6.02	4.10	98.40%	-30.90%	-22.21%
ACIU	AC IMMUNE SA	$260.46M	-124.00%	-40.50%	-146.14%	1,976.70%	3.36	0.87	100.00%	-1,788.80%	-1,783.31%
NBTX	NANOBIOTIX SA	$1.74B	N/A	-35.50%	-85.10%	-27.90%	-1.80	1.09	100.00%	-73.50%	-26.77%
TRAX	FIRST TRACKS BIOTHERAPEUTICS INC	$559.32M	N/A	N/A	N/A	N/A	0.13	8.74	N/A	N/A	N/A
KARD	KARDIGAN INC	N/A	N/A	N/A	N/A	N/A	-0.17	9.42	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #1 top biotech stock out of 608 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 34, which is 10 points higher than the biotech industry average of 24.

JAZZ passed 11 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 113.95% over the past year, overperforming other biotech stocks by 186 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $259.25, an upside of 12.71% from Jazz Pharmaceuticals's current stock price of $230.02.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Jazz Pharmaceuticals, 66.67% have issued a Strong Buy rating, 25% have issued a Buy, 8.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top biotech stock out of 608 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: C, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -5 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates ICCC as a "A".

ICCC passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 44.18% over the past year, overperforming other biotech stocks by 116 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the #3 top biotech stock out of 608 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: B.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 45, which is 21 points higher than the biotech industry average of 24.

EXEL passed 15 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 27.11% over the past year, overperforming other biotech stocks by 99 percentage points.

Exelixis has an average 1 year price target of $49.44, a downside of -9.72% from Exelixis's current stock price of $54.77.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Exelixis, 11.11% have issued a Strong Buy rating, 22.22% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Centessa Pharmaceuticals (NASDAQ:CNTA)

Centessa Pharmaceuticals (NASDAQ:CNTA) has an annual dividend yield of 93.83%, which is 77 percentage points higher than the biotech industry average of 17.22%.

Centessa Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 33.28%, which is 16 percentage points higher than the biotech industry average of 17.22%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.35%, which is -12 percentage points lower than the biotech industry average of 17.22%.

Oramed Pharmaceuticals's dividend payout ratio of 9.4% indicates that its high dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.86% in the last day, and up 4.5% over the last week. Hemab Therapeutics Holdings was the among the top gainers in the biotechnology industry, gaining 16.77% yesterday.

Hemab Therapeutics Holdings shares are trading higher after the company announced it will present clinical and preclinical data from multiple blood coagulation programs at ISTH 2026.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Cormedix (NASDAQ:CRMD)

Cormedix (NASDAQ:CRMD) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Cormedix has a valuation score of 43, which is 31 points higher than the biotech industry average of 12. It passed 3 out of 7 valuation due diligence checks.

Cormedix's stock has dropped -47.53% in the past year. It has overperformed other stocks in the biotech industry by 24 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 45 points higher than the biotech industry average of 12. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 11.33% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

3. Biomarin Pharmaceutical (NASDAQ:BMRN)

Biomarin Pharmaceutical (NASDAQ:BMRN) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Biomarin Pharmaceutical has a valuation score of 29, which is 17 points higher than the biotech industry average of 12. It passed 2 out of 7 valuation due diligence checks.

Biomarin Pharmaceutical's stock has gained 9.06% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

Are biotech stocks a good buy now?

68.48% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 52.71% over the next year.

2.59% of biotech stocks have a Zen Rating of A (Strong Buy), 3.88% of biotech stocks are rated B (Buy), 45.26% are rated C (Hold), 36.64% are rated D (Sell), and 11.64% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.11x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Immucell (NASDAQ:ICCC)

3. Exelixis (NASDAQ:EXEL)

1. Centessa Pharmaceuticals (NASDAQ:CNTA)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Cormedix (NASDAQ:CRMD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Biomarin Pharmaceutical (NASDAQ:BMRN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Immucell (NASDAQ:ICCC)

3. Exelixis (NASDAQ:EXEL)

1. Centessa Pharmaceuticals (NASDAQ:CNTA)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Cormedix (NASDAQ:CRMD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Biomarin Pharmaceutical (NASDAQ:BMRN)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.